Market review

Market Review

The annual value of the global pharmaceutical market is approximately EUR 600 billion. Oriola operates on a pharmaceutical market worth approximately EUR 16 billion.

Pharmaceutical market in Sweden

In Sweden, the pharmacy monopoly ended in 2009, as a result of which new business models have surfaced on the wholesale market. Following the change in the market, new providers of logistics services have entered the Swedish market alongside the single-channel model.

At the end of 2010, approximately 1 200 pharmacies were operating in Sweden, an increase with 202 pharmacies during 2010. Prescription medicines accounted for approximately 80 per cent of pharmacies’ total sales. OTC pharmaceuticals accounted for about 10 per cent of pharmacies’ net sales and the sale of traded goods accounts for around 10 per cent of pharmacies’ net sales.

Pharmaceutical market in other European countries

There are two leading pharmaceutical wholesalers in Finland. In Finland, pharmaceutical distribution takes place with a single-channel model in which pharmaceutical manufacturers focus the distribution of their products on a single pharmaceutical wholesaler.

The Russian and Baltic pharmaceutical distribution markets operate under a multi-channel model, in which pharmaceutical companies sell medicines to multiple pharmaceutical wholesale companies.

In Europe, the pharmaceutical wholesale market operates mainly under the multi-channel model. The single-channel model resembles the direct to pharmacy (DTP) model, which is becoming more common in Europe especially between major pharmaceutical companies and pharmaceutical wholesalers.

Oriola on pharmaceutical market

*IMS Health